Home > News > Biophan Details Technology License and Investment Agreements
July 8th, 2005
Biophan Details Technology License and Investment Agreements
Abstract:
Biophan Technologies, Inc., a developer of next-generation biomedical technology, further detailed the terms of its technology licensing and equity agreements with leading medical device manufacturer Boston Scientific Corporation in an SEC Form 8-K/A filed today.
Source:
businesswire
Bookmark:
Investments/IPO's/Splits
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanostart-holding New Asia Investments invests in breakthrough water projects May 13th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013